What is Shouyao Holdings (Beijing) Co., LTD.'s (688197.SS) StockRank?

MoatMap's StockRank for Shouyao Holdings (Beijing) Co., LTD. (688197.SS) is 19/100, with a Strong Sell signal. This is a composite score combining Quality (37), Value (35), and Momentum (37) factor ranks across MoatMap's 19,000+ stock universe.

Does Shouyao Holdings (Beijing) Co., LTD. have an economic moat?

Shouyao Holdings (Beijing) Co., LTD. (688197.SS) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shouyao Holdings (Beijing) Co., LTD. a buy, hold, or sell?

MoatMap's current signal for Shouyao Holdings (Beijing) Co., LTD. (688197.SS) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shouyao Holdings (Beijing) Co., LTD. in?

Shouyao Holdings (Beijing) Co., LTD. (688197.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688197.SS

STRONG SELLREMOVE

Shouyao Holdings (Beijing) Co., LTD. · Healthcare · China · $804M · Avg Vol: $8M/d

StockRank

P/E (TTM)

—

ROE

-13.1%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Early-stage oncology drug developer with weak quality metrics (Q: 36) and no commercialized portfolio. It does not possess the validated manufacturing assets of a CDMO and is highly speculative.

COMPANY DESCRIPTION

Shouyao Holdings (Beijing) Co., LTD. researches and develops innovative small-molecule oncology drugs, focusing on targeted therapies for non-small cell lung cancer (NSCLC) and other cancers. The company's competitive moat is defined by its robust pipeline of ALK, ROS1, and BTK inhibitors with potential best-in-class efficacy profiles. It is a clinical-stage biotechnology company characterized by strong independent R&D capabilities and strategic domestic partnerships.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	270,048	772,834	582,606	1M	68.0%
EPS	-0.18	-0.18	-0.21	-0.13	—
Shares	149M	149M	149M	149M	0.0%
Debt	1M	449,030	957,840	2M	19.0%
Equity	178M	151M	120M	101M	-17.4%
Op CF	-19M	-27M	-29M	-23M	—
Inv CF	-11M	-70M	-45M	23M	—
Fin CF	202M	-770,640	-777,101	-708,439	—

PRICE (1M)-22.9%

SMA 50SMA 200

$4.66

RSI (14)

26.3

52W High

$8.40

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-18.7%29.2

ROE

-13.1%33.7

GP/Assets

4.4%17.4

Op. Margin

-63.8%19.6

FCF/Assets

-14.9%22.4

Piotroski

—7.2

Int. Cover

-50.0x6.5

D/E Ratio

0.02x83.0

Current Ratio

6.89x79.7

Value

P/E (TTM)

—N/A

EV/EBITDA

-25.5x89.0

P/FCF

—N/A

P/B

7.0x16.6

P/S

135.2x6.5

Div Yield

—N/A

Momentum

52W High %

55%30.9

RS 6M

-25%47.3

SMA 50/200

0.97x53.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$804M

P/E (Forward)

—

Gross Margin

99.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688197.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688197.SS	Shouyao Holdings (Beijing) Co., LTD.(you)	$804M	19	STRONG SELL
2256.HK	Abbisko Cayman Limited	$826M	18	STRONG SELL
688639.SS	Anhui Huaheng Biotechnology Co., Ltd.	$868M	17	STRONG SELL
2105.HK	Laekna, Inc.	$666M	15	STRONG SELL
2157.HK	Lepu Biopharma Co., Ltd.	$981M	15	STRONG SELL
300149.SZ	ChemPartner PharmaTech Co.,Ltd.	$642M	15	STRONG SELL
688302.SS	Hinova Pharmaceuticals Inc.	$582M	14	STRONG SELL
688075.SS	Assure Tech (Hangzhou) Co., Ltd.	$643M	27	SELL
300294.SZ	China Resources Boya Bio-pharmaceutical Group Co.,Ltd	$1.2B	16	STRONG SELL
688488.SS	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	$965M	28	SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.0%

Shouyao Holdings (Beijing) Co., LTD. (688197.SS) — Stock Score Summary

Shouyao Holdings (Beijing) Co., LTD. (688197.SS) has a MoatMap StockRank of 19/100 based on Quality (37/100), Value (35/100), and Momentum (37/100) factor scores. The current signal is STRONG SELL. Early-stage oncology drug developer with weak quality metrics (Q: 36) and no commercialized portfolio. It does not possess the validated manufacturing assets of a CDMO and is highly speculative.

Key Financial Metrics

Price	$4.66
Market Cap	$804M
Price/Book	7.05
Return on Equity	-13.1%
Return on Invested Capital	-18.7%
Debt/Equity	1.90
Gross Margin	99.2%
Operating Margin	-63.8%
Revenue Growth	1300.0%
Free Cash Flow	$-3M

Shouyao Holdings (Beijing) Co., LTD. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shouyao Holdings (Beijing) Co., LTD.’s (688197.SS) StockRank?: MoatMap’s StockRank for Shouyao Holdings (Beijing) Co., LTD. (688197.SS) is 19/100, with a Strong Sell signal. It is a composite of Quality (37), Value (35), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shouyao Holdings (Beijing) Co., LTD. have an economic moat?: Shouyao Holdings (Beijing) Co., LTD. (688197.SS) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shouyao Holdings (Beijing) Co., LTD. a buy, hold, or sell?: MoatMap’s current signal for Shouyao Holdings (Beijing) Co., LTD. (688197.SS) is Strong Sell, based on a StockRank of 19/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shouyao Holdings (Beijing) Co., LTD. in?: Shouyao Holdings (Beijing) Co., LTD. (688197.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).